Trial Profile
A Prospective Longitudinal Study Evaluating the Factors Associated with Increased Serum Cholesterol Levels during Interferon-Free (IFN-free) Hepatitis C Virus (HCV) Therapy
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 06 Apr 2018
Price :
$35
*
At a glance
- Drugs Ledipasvir/sofosbuvir (Primary) ; Ombitasvir/paritaprevir/ritonavir (Primary)
- Indications Hepatitis C
- Focus Pharmacodynamics; Therapeutic Use
- 06 Apr 2018 New trial record
- 27 Mar 2018 Results published in the JAIDS:Journal of Acquired Immune Deficiency Syndromes.